Temasek Holdings
http://www.temasekholdings.com.sg/Temasek Holdings is an Asian investment firm headquartered in Singapore. Its portfolio spans various industries including telecommunications & media, financial services, real estate, transportation & logistics, energy & resources, infrastructure, engineering & technology as well as bioscience & healthcare. As of March 2007, the net value of its portfolio is more than US$100 billion, concentrated principally in Singapore, Asia and the OECD economies. Temasek's total shareholder return since its inception in 1974 has been more than 18% compounded annually. It has a corporate credit rating of AAA/Aaa by rating agencies Standard & Poor's and Moody's respectively.
In December of 2007, Temasek Holdings invested $4.4 billion in Merrill Lynch (NYSE: MER) common stock.
View Older Stories View More Recent Stories
-
WebMD Announces 2020 Health Heroes
-
Centurium Capital and Certain Other Investors File a Transaction Statement on Schedule 13E-3 with the U. S. Securities and Exchange Commission
-
Boardspan and Trusted Services (a Temasek Management Services Company) Announce Partnership to Provide Cloud-Based Governance Solutions
-
Form 13F-HR Temasek Holdings (Privat For: Dec 31
-
Form 13F-NT Temasek Life Sciences For: Dec 31
-
Form 13F-NT Temasek Capital (Private For: Dec 31
-
Exclusive: Thyssenkrupp-Kone elevator merger would trigger legal war - Schindler
-
Bankers in Asia brace for a virus-related deal drought
-
Wayback Burgers Offers a Plant-Based Burger Just in Time for Lent
-
Capriotti's Does the Impossible, Launches First Impossible Cheese Steak Sandwich Nationwide!
-
Iora Health Closes $126 Million Series F Funding Round
-
Form SC 13G/A PORTOLA PHARMACEUTICALS Filed by: Temasek Holdings (Private) Ltd
-
Form SC 13G/A Orchard Therapeutics Filed by: Temasek Holdings (Private) Ltd
-
Form SC 13G/A NIO Inc. Filed by: Temasek Holdings (Private) Ltd
-
Form SC 13G/A Tuniu Corp Filed by: Temasek Holdings (Private) Ltd
-
Form SC 13G/A Coherus BioSciences, Filed by: Temasek Holdings (Private) Ltd
-
Ups and downs: the battle to buy Thyssenkrupp's elevator unit
-
Impossible Foods Hires Biotech Executive and Startup Founder Brian Miller as Chief People Officer
-
iSTOX Graduates From MAS Regulatory Sandbox: Now A Fully Regulated DLT-Based Capital Markets Platform
-
Form SC 13G/A Dell Technologies Inc Filed by: Temasek Holdings (Private) Ltd
-
Stem Launches Partner Program to Expand Its Turnkey Storage Solution into the Broader Commercial and Industrial Solar Markets
-
Indonesia to step up data protection with new bill amid booming digital economy
-
Weyland Tech Reports 2019 Preliminary Results: Revenue up 53% to Record $34.6 Million, Driving First Quarter of Positive Adj. EBITDA
-
Form SC 13D/A China Biologic Products Filed by: Temasek Holdings (Private) Ltd
-
Lab-grown meat producer Memphis Meats raises $161 million in funding led by SoftBank
-
Exclusive: Eurazeo hires banks for $2.2 billion sale of payments firm Planet - sources
-
With Breakthrough $161 Million Series B Funding Round, Leading Cell-Based Meat Company Memphis Meats Aims To Bring Products To Consumers For the First Time
-
iQIYI Partners with MBT and Panabit to Bring HD 4K Blu-ray Streaming Services "Qisubo" to Myanmar
-
Sagara Technology: Providing an End-to-End Solution for US Company to Go-Digital
-
WebMD Health Services Launches New, Personalized Experiences for Health Plans and their Senior Members
-
Exclusive: Temasek, Trustbridge target majority stake in WeWork China at $1 billion valuation – sources
-
Stem Earns Place in Prestigious 2020 Global Cleantech 100
-
WebMD Health Services Launches New, Personalized Experiences for Health Plans and their Senior Members
-
Medscape's 2020 Physician Burnout Report Finds Main Causes and Coping Mechanisms Differ by Generation
-
Califia Farms Completes Landmark $225 Million Financing with Diverse Group of Global Investors
-
WebMD Launches WebMD Care, Connecting Consumers to Health Care Professionals
-
SingleCare Partners With WebMD to Launch WebMDRx, Offering Consumers up to 80% Savings on Prescription Drugs
-
Travel app Omio the latest Berlin startup to take on North America
-
iSTOX Secures Funding Of USD 5 Million From Korea's Hanwha Asset Management
-
Brookfield, Temasek team up for Thyssenkrupp elevator bid: sources
-
Soul Machines Raises US$40M Series B From Global Investment Community to Advance the Way Humans and Machines Collaborate
-
Soul Machines Raises US$40M Series B From Global Investment Community to Advance the Way Humans and Machines Collaborate
-
Transcenta Holding Secures $100 Million Series B Plus Financing
-
ClassPass Raises $285 Million to Accelerate International Growth and Scale Corporate Program
-
BURGER KING® Restaurants Test the Impossible™ Croissan’wich®
-
Impossible Foods Serves up Impossible™ Pork Made from Plants and Impossible™ Sausage Made from Plants -- The Startup’s First All-New Products Since the Blockbuster Impossible™ Burger
-
AXELL and Blaize Collaborate to Integrate Blaize AI Processing Technology Into AXELL ailia AI Framework
-
Indonesia plans fixed fees for e-wallet transactions: sources
-
Temasek-backed fitness app ClassPass eyes $1 billion valuation in new funding round
-
Form SC 13D/A Univar Solutions Inc. Filed by: Temasek Holdings (Private) Ltd

